Lilly is committed to the highest standards of corporate conduct in all of our business dealings globally. Lilly maintains an effective ethics and compliance program designed to meet external requirements, guided by our core values and code of business conduct, The Red Book. It is our expectation that Lilly employees will comply with The Red Book and the policies that have been established in support of that code. We periodically review and enhance the ethics and compliance program to meet changing business needs and external requirements.
Lilly’s ethics and compliance program is a central component of how business is conducted and has oversight from the board of directors’ Public Policy and Compliance Committee. The fundamental elements of our ethics and compliance program are outlined below.
Chief ethics and compliance officer: Lilly has appointed a Chief Ethics and Compliance Officer to lead ethics and compliance activities. The Chief Ethics and Compliance Officer has the ability to lead change within the organization and is responsible for developing, operating, and monitoring the compliance program. The Chief Ethics and Compliance Officer reports directly to the Lilly Chief Executive Officer and to the Public Policy and Compliance Committee of the Board of Directors.
Compliance and Enterprise Risk Management Committee: Lilly has established a Compliance and Enterprise Risk Management Committee to advise the Chief Ethics and Compliance Officer and to assist in the implementation of the ethics and compliance program. The committee is chaired by the Chief Ethics and Compliance Officer and submits reports on the state of Lilly’s ethics and compliance program to the Public Policy and Compliance Committee of the company Board of Directors multiple times per year.
Lilly’s Code of Business Conduct, The Red Book, is the statement of principles that guide the company’s operations. The Red Book outlines Lilly’s core values as well as the expectation and framework for ethical and compliant behavior by those who work for Lilly or on behalf of the company. For more information, download The Red Book.
The Red Book directs management and employees of the company globally to act in accordance with laws, other legal requirements, and applicable company policies. Lilly also provides for its employees more detailed policies, standards and procedures that establish expectations for ethical and compliant behavior. The Red Book includes references to company policies that apply globally, as well as examples to illustrate application of The Red Book principles.
Education and Training
A critical element of Lilly’s ethics and compliance program is the continuing training and education of its employees on application of the core Lilly values, and individual obligations under applicable legal requirements and company policies. Lilly trains all its employees on The Red Book, including its content and application to daily activities. Lilly also provides targeted training in key risk areas to those employees whose job functions are affected by those risk areas.
Internal Lines of Communication
Lilly is committed to fostering dialogue between management and employees through multiple channels. Supervisors are expected to maintain an environment that promotes open communication.
Lilly’s goal is that employees know where to turn when they are seeking answers to questions or reporting potential instances of fraud and abuse, or other potential violations of law, regulations, or company policies. Employees may submit reports through their management, or to human resources, a company attorney, the ethics and compliance department, the general auditor, or the chief ethics and compliance officer. Lilly has also established a hotline which is available to employees 24 hours a day, 7 days a week, through which potential violations of legal obligations and policies may be reported. Anonymity and translation services are available. Reports may be submitted by telephone to 1-800-815-2481 or on-line at Lilly EthicsPoint. Some local limitations apply to reports submitted from outside the United States to comply with local laws.
Lilly does not tolerate retaliation by any individual against another for good faith reports of potential violations of law, regulations, or company policies. See The Red Book for further information.
Auditing and Monitoring
Lilly’s ethics and compliance program includes ongoing efforts to assess, evaluate, monitor, and audit compliance with the company’s ethics and compliance policies and procedures. The nature, extent, and frequency of these activities depend on a variety of factors, including new regulatory requirements, changes in business practices, and other considerations.
Auditing, monitoring, and assessment activities are conducted annually, and results are reported to local management and corporate governance committees.
Responding to Potential Violations
Lilly’s ethics and compliance program includes disciplinary principles that set out the consequences to individuals who violate the law, regulations, or company policies. Although each situation is considered on a case-by-case basis, Lilly imposes discipline to address inappropriate conduct and to deter future violations. See The Red Book for further details.
In addition to imposing appropriate disciplinary action, the company also assesses whether a violation may be due in part to gaps in Lilly’s policies, training, business practices, or other controls. If so, the company is committed to implementing corrective measures to enhance its controls to prevent further violations.